About Our Expertise
At Lambe Analytics Limited, we provide unparalleled expertise in health economics and outcome research consultancy. Our dedication is to offer methodologically robust services that support organisations and individuals in making informed decisions.
We also provide significant value by guiding clients through the development of effective reimbursement strategies, creating sophisticated health economic models, conducting outcome research studies, and providing crucial support in navigating complex market access challenges. We excel in synthesising evidence, crafting compelling value propositions, and preparing packages for Health Technology Assessments (HTA). Our commitment to regulatory support ensures seamless integration of health economic insights into submissions, enhancing the overall value proposition of our clients' healthcare products or services
Our mission is to ensure that our clients have access to bespoke solutions that meet their unique needs, leveraging our extensive experience and industry knowledge. We are committed to delivering excellence in every aspect of our work, and we take pride in being a valuable partner in driving positive outcomes.
-
Economic Evaluation
We have extensive experience conducting economic evaluations alongside clinical trials, building de novo cost effectiveness models and adapting global cost effectiveness models to support local technology appraisals.
-
Health Outcome Research
Our team are skilled in identifying the most appropriate instrument for capturing relevant health outcomes for specific purposes. We can analyse the reported response to instruments to demonstrate the effectiveness of a drug, device, service redesign or intervention.
-
Evidence Synthesis
We use thorough methodologies to generate evidence-based answers to clinical, epidemiological, economic and modelling queries. We are able to conduct systematic reviews with or without network meta-analysis, rapid reviews, scoping reviews and much more.
-
Health System Advisory
We provide advisory services to local NHS organisations and international public organisations at the national and local levels. Routinely collected data within organisations may be used to identify areas for improvement, estimate return on investment and predict the impact of reprioritisation decisions.